Podcast

Pharmacy Focus Episode 38: The Revolutionary Impact of Dupilumab on Skin Conditions

Author(s):

Jill Murphy, Associate Editor

Dupilumab has been a breakthrough treatment for patients with atopic dermatitis, but future studies are needed to continue learning about its strength.

In this week’s episode, we will be discussing dupilumab and its impact on atopic dermatitis with Dr. Peter Lio. If you would like to nominate a pharmacist or pharmacy staff member as a Pharmacy Hero, email AAntrim@pharmacytimes.com!

Related Videos
Trisha Winroth, PharmD, and Ashly McPhillips, PharmD
Ashley Pugh, PharmD, and Lauren Angelo, PharmD, MBA
Image Credit: © Анастасія Стягайло - stock.adobe.com
Patient suffering from atopic dermatitis -- Image credit: Nikkikii | stock.adobe.com
Atopic dermatitis on a patient's hand -- Image credit: Ольга Тернавская | stock.adobe.com
Man receiving medication infusion | Image credit: Studio Romantic - stock.adobe.com
Related Content
Dry hands with wounds. Dry hands with wounds. Hand cream. White background - Image credit: Veronika Klim | stock.adobe.com
September 23rd 2024

FDA Accepts New Drug Application for Delgocitinib Cream to Treat Chronic Hand Eczema

Kennedy Ferruggia, Assistant Editor
Pharmacy Focus - Oncology Edition: Advancing Brain Cancer Research and Treatment
September 26th 2024

Pharmacy Focus - Oncology Edition: Advancing Brain Cancer Research and Treatment

Image Credit: © Shutter2U - stock.adobe.com
September 17th 2024

Long-Term Survival Rates Improve with Dual Immunotherapy in Metastatic Melanoma

Alexandra Gerlach, Associate Editor
Public Health Matters podcast logo
September 19th 2024

Public Health Matters: The Difference Between Misinformation and Disinformation, and How Information Can Inform Evidence-Based Decisions

Emerging Frontiers: The Gut Microbiome's Role in Enhancing Cancer Immunotherapy and Treatment Outcomes
September 14th 2024

Emerging Frontiers: The Gut Microbiome's Role in Enhancing Cancer Immunotherapy and Treatment Outcomes

Alana Hippensteele, Managing Editor
B-cell, white blood cell 3D, type of lymphocyte interacting with a virus. Adaptive immune response, CAR-T cell therapy.
September 13th 2024

Atezolizumab and Hyaluronidase-tqjs Subcutaneous Formulation Receives FDA Approval to Treat Multiple Forms of Cancer

Luke Halpern, Assistant Editor